Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2005;46:1032-1038
Published online before print September 12, 2005, doi: 10.1161/01.HYP.0000176588.51027.35
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
46/4/1032    most recent
01.HYP.0000176588.51027.35v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Callera, G. E.
Right arrow Articles by Touyz, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Callera, G. E.
Right arrow Articles by Touyz, R. M.
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow CT and MRI
Right arrow Oxidant stress

(Hypertension. 2005;46:1032.)
© 2005 American Heart Association, Inc.


Part 2 Original Articles

c-Src–Dependent Nongenomic Signaling Responses to Aldosterone Are Increased in Vascular Myocytes From Spontaneously Hypertensive Rats

Glaucia E. Callera; Augusto C. I. Montezano; Alvaro Yogi; Rita C. Tostes; Ying He; Ernesto L. Schiffrin; Rhian M. Touyz

From the Ottawa Health Research Institute (G.E.C., Y.H., R.M.T.), University of Ottawa, Ottawa, Canada; the CIHR Multidisciplinary Research Group on Hypertension (A.C.I.M., E.L.S., R.M.T.), Clinical Research Institute of Montreal, University of Montreal, Montreal, Canada; and the Department of Pharmacology (A.C.I.M., A.Y., R.C.T.), Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil.

Correspondence to Glaucia E. Callera, Kidney Research Centre, Ottawa Health Research Institute, University of Ottawa, Health Sciences Bldg, Room 1333A, 451 Smyth Rd, Ottawa, Ontario K1H 8M5, Canada. E-mail gcallera{at}uottawa.ca

Aldosterone plays an important role in the pathogenesis of hypertension. We previously demonstrated that nongenomic signaling by aldosterone in vascular smooth muscle cells occurs through c-Src–dependent pathways. Here we tested the hypothesis that upregulation of c-Src by aldosterone plays a role in increased mitogen-activated protein (MAP) kinase activation, [3H]-proline incorporation, and NADPH-driven generation of reactive oxygen species, thereby inducing cell growth, collagen production, and inflammation, respectively, in vascular smooth muscle cells from spontaneously hypertensive rats. The time course of c-Src phosphorylation by aldosterone was shifted to the left in vascular myocytes from hypertensive animals. Aldosterone rapidly increased phosphorylation of p38 MAP kinase and extracellular signal–regulated kinase with significantly greater effects in cells from spontaneously hypertensive rats versus control cells (P<0.05). Aldosterone increased NADPH oxidase activity with significantly greater responses in vascular smooth muscle cells from hypertensive animals (P<0.05). These events were associated with enhanced [3H]proline incorporation (index of collagen synthesis) in cells from spontaneously hypertensive rats (P<0.05). The NADPH oxidase activity increase, collagen synthesis, c-Src, and MAP kinase phosphorylation induced by aldosterone were significantly reduced by eplerenone (selective mineralocorticoid receptor blocker) and PP2 (selective c-Src inhibitor). In conclusion, nongenomic signaling by exogenous aldosterone, mediated through c-Src, is increased in vascular smooth muscle cells from spontaneously hypertensive rats. Upregulation of c-Src signaling may be important in the profibrotic and proinflammatory actions of aldosterone in this genetic model of hypertension.


Key Words: aldosterone • signal transduction • rats, inbred SHR • oxidative stress • collagen




This article has been cited by other articles:


Home page
Circ. Res.Home page
C. A. Lemarie, S. M.C. Simeone, A. Nikonova, T. Ebrahimian, M.-E. Deschenes, T. M. Coffman, P. Paradis, and E. L. Schiffrin
Aldosterone-Induced Activation of Signaling Pathways Requires Activity of Angiotensin Type 1a Receptors
Circ. Res., October 23, 2009; 105(9): 852 - 859.
[Abstract] [Full Text] [PDF]


Home page
Ther Adv Cardiovasc DisHome page
M. M. Shafiq and A. B. Miller
Blocking aldosterone in heart failure
Therapeutic Advances in Cardiovascular Disease, October 1, 2009; 3(5): 379 - 385.
[Abstract] [PDF]


Home page
EndocrinologyHome page
N. Lopez-Andres, C. Inigo, I. Gallego, J. Diez, and M. A. Fortuno
Aldosterone Induces Cardiotrophin-1 Expression in HL-1 Adult Cardiomyocytes
Endocrinology, October 1, 2008; 149(10): 4970 - 4978.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
L. H. Cavallari, L. A. Fashingbauer, J. R. Camp, S. T. King, and D. L. Geenen
Hypertension-induced renal fibrosis and spironolactone response vary by rat strain and mineralocorticoid receptor gene expression
Journal of Renin-Angiotensin-Aldosterone System, September 1, 2008; 9(3): 146 - 153.
[Abstract] [PDF]


Home page
HypertensionHome page
K. Graf, T. Hucko, and P. Stawowy
Cardiac Benefits of Mineralocorticoid Receptor Inhibition in Renal Failure
Hypertension, August 1, 2008; 52(2): 209 - 210.
[Full Text] [PDF]


Home page
HypertensionHome page
J. H. Westhoff, K. F. Hilgers, M. P. Steinbach, A. Hartner, B. Klanke, K. Amann, and A. Melk
Hypertension Induces Somatic Cellular Senescence in Rats and Humans by Induction of Cell Cycle Inhibitor p16INK4a
Hypertension, July 1, 2008; 52(1): 123 - 129.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Sontia, A. C.I. Montezano, T. Paravicini, F. Tabet, and R. M. Touyz
Downregulation of Renal TRPM7 and Increased Inflammation and Fibrosis in Aldosterone-Infused Mice: Effects of Magnesium
Hypertension, April 1, 2008; 51(4): 915 - 921.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
D.-P. Li, Q. Yang, H.-M. Pan, and H.-L. Pan
Pre- and postsynaptic plasticity underlying augmented glutamatergic inputs to hypothalamic presympathetic neurons in spontaneously hypertensive rats
J. Physiol., March 15, 2008; 586(6): 1637 - 1647.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Grossmann, R. Freudinger, S. Mildenberger, B. Husse, and M. Gekle
EF Domains Are Sufficient for Nongenomic Mineralocorticoid Receptor Actions
J. Biol. Chem., March 14, 2008; 283(11): 7109 - 7116.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Yu, S.-G. Wei, Z.-H. Zhang, E. Gomez-Sanchez, R. M. Weiss, and R. B. Felder
Does Aldosterone Upregulate the Brain Renin-Angiotensin System in Rats With Heart Failure?
Hypertension, March 1, 2008; 51(3): 727 - 733.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z.-H. Zhang, Y. Yu, Y.-M. Kang, S.-G. Wei, and R. B. Felder
Aldosterone acts centrally to increase brain renin-angiotensin system activity and oxidative stress in normal rats
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H1067 - H1074.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Yogi, G.E. Callera, A.C.I. Montezano, A.B. Aranha, R.C. Tostes, E.L. Schiffrin, and R.M. Touyz
Endothelin-1, but not Ang II, Activates MAP Kinases Through c-Src-Independent Ras-Raf-Dependent Pathways in Vascular Smooth Muscle Cells
Arterioscler Thromb Vasc Biol, September 1, 2007; 27(9): 1960 - 1967.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Otani, F. Otsuka, K. Inagaki, M. Takeda, T. Miyoshi, J. Suzuki, T. Mukai, T. Ogura, and H. Makino
Antagonistic effects of bone morphogenetic protein-4 and -7 on renal mesangial cell proliferation induced by aldosterone through MAPK activation
Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1513 - F1525.
[Abstract] [Full Text] [PDF]